Q2 2021 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Hello, and welcome to the Aurinia Pharmaceuticals second quarter earnings call and webcast. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Glenn Schulman, Head of Investor Relations. Please go ahead.
Thanks, Kevin, and thanks all for joining us today as we discuss Aurinia's second quarter financial results. Joining me on the call this afternoon are Peter Greenleaf, President and CEO; Joe Miller, our Chief Financial Officer; Max Colao, our Chief Commercial Officer; and Neil Solomons, our Chief Medical Officer here at Aurinia.
Our agenda for today, Peter will provide a review of the LUPKYNIS launch date, our outlook for the rest of the year, along with our ongoing clinical and regulatory activities. From there, Joe will discuss our financial performance in more detail and then after some closing remarks from Peter, the whole team will be here and available for your questions.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
